Authors: SABRI K PANDIT JC THALLER VT EVANS NM CROCKER GR

Citation: K. Sabri et al., NATIONAL SURVEY OF CORNEAL ABRASION TREATMENT, Eye, 12, 1998, pp. 278-281

Authors: SABRI K

Citation: K. Sabri, HIGH PREVALENCE OF RECURRENT SYMPTOMS FOLLOWING UNCOMPLICATED TRAUMATIC CORNEAL ABRASION - REPLY, British journal of ophthalmology, 82(7), 1998, pp. 850-850

Authors: DUNN FW ROUX MH FARHADIAN F SABRI K OSSART C SAMUEL JL RAPPAPORT L HAMON G

Citation: Fw. Dunn et al., HR-720, A NOVEL ANGIOTENSIN RECEPTOR ANTAGONIST INHIBITS THE ANGIOTENSIN-II-INDUCED TROPHIC EFFECTS, FIBRONECTIN RELEASE AND FIBRONECTIN-EIIIA(-MUSCLE CELLS IN-VITRO() EXPRESSION IN RAT AORTIC VASCULAR SMOOTH), The Journal of pharmacology and experimental therapeutics, 280(1), 1997, pp. 447-453

Authors: SABRI K PANDIT JC THALLER VT EVANS NM CROCKER GR

Citation: K. Sabri et al., CURRENT MANAGEMENT OF CORNEAL ABRASIONS - EVIDENCE BASED PRACTICE, British journal of ophthalmology, 81(12), 1997, pp. 1116-1117

Authors: SABRI K HARVEY I

Citation: K. Sabri et I. Harvey, THE PREVENTION OF SKIN-CANCER - IS THERE A GAP BETWEEN EVIDENCE AND PRACTICE, Public health, 110(6), 1996, pp. 347-350